This article reviews two large studies from The American Journal of Psychiatry that evaluated whether telehealth prescribing of stimulants for attention-deficit/hyperactivity disorder (ADHD) increases substance misuse risk. Findings suggest that while overall risk of developing a substance use disorder was not higher with telehealth, patients starting stimulants via telehealth appeared more likely to develop a stimulant use disorder—likely reflecting underlying patient characteristics rather than the telehealth encounter itself.